Avecia has sold its vaccines business to PharmAthene for $20m. Avecia will also be eligible for $20m in milestone payments. The business will remain in the UK.
Baltimore Buisiness Journal
Friday 21 March 2008
Avecia sells vaccines
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment